Skip to main content

Table 1 Number of deaths and patients at risk for every consecutive 2-month period as extracted from digitized survival curves (see appendix for details)

From: Network meta-analysis of survival data with fractional polynomials

Study 1

Study 2

Study 3

Study 4

Study 5

Study 6

Study 7

Lee et al., 2010

Chang et al. 2006

Kim et al., 2008

Maruyama et al., 2008

Hanna et al., 2004

Cufer et al., 2006

Shepherd et al., 2000

Gefitinib

Docetaxel

BSC

Gefitinib

Gefitinib

Docetaxel

Gefitinib

Docetaxel

Pemtrexed

Docetaxel

Gefitinib

Docetaxel

BSC

Docetaxel

r

n

r

n

r

N

r

n

r

n

r

n

r

n

r

n

r

n

r

n

r

n

r

n

r

n

r

n

7

81

9

76

22

107

34

235

98

723

73

710

18

245

9

244

27

283

33

288

11

68

14

73

17

222

49

441

5

74

4

67

24

85

35

201

104

625

109

637

30

226

21

233

47

256

48

255

8

57

11

59

71

205

67

392

7

69

8

64

11

61

29

166

94

518

102

503

25

197

23

214

31

209

41

207

5

49

6

48

53

134

60

325

6

62

5

56

8

50

15

137

79

424

66

401

22

169

15

189

33

178

21

166

14

44

6

42

70

160

63

340

6

55

8

51

12

42

11

122

64

336

68

339

12

148

23

173

40

144

34

144

9

31

7

36

12

90

49

277

3

49

4

38

6

30

14

110

46

272

41

271

18

127

17

140

17

78

17

78

4

21

4

29

22

78

14

228

4

46

6

34

1

24

1

97

35

225

32

228

10

98

9

105

21

61

13

61

8

18

    

55

221

3

42

2

28

    

30

190

29

196

8

77

10

87

8

40

18

48

      

41

166

3

38

4

26

    

14

131

18

139

6

63

15

69

11

33

9

30

      

30

125

3

35

3

22

    

14

117

16

121

4

47

4

44

  

10

21

        

5

29

3

18

    

14

83

13

89

3

35

5

35

            

4

24

2

15

    

8

69

10

76

1

29

3

25

            

3

21

1

13

    

5

50

6

46

1

25

2

18

            

1

18

1

12

    

3

45

5

40

2

18

1

14

            

3

17

2

10

    

6

31

4

24

  

1

10

            

3

14

2

8

      

3

20

                

1

12